Standardized peptidome profiling of human cerebrospinal fluid by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

被引:28
作者
Bruegel, Mathias [1 ]
Planert, Mathis [1 ]
Baumann, Sven [1 ]
Focke, Almut [2 ]
Bergh, Florian Then [2 ]
Leichtle, Alexander [1 ]
Ceglarek, Uta [1 ]
Thiery, Joachim [1 ]
Fiedler, Georg Martin [1 ]
机构
[1] Univ Hosp Leipzig, Inst Lab Med Clin Chem & Mol Diagnost, D-04103 Leipzig, Germany
[2] Univ Hosp Leipzig, Dept Neurol, D-04103 Leipzig, Germany
关键词
Cerebrospinal fluid; MALDI-TOF; Mass spectrometry; Peptidome; Proteome; Standardization; PLASMA-PROTEOME; HUMAN SERUM; BIOMARKERS; SCLEROSIS; IMPACT;
D O I
10.1016/j.jprot.2008.11.018
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Peptidome profiling of human cerebrospinal fluid (CSF) is a promising tool to identify novel disease-associated biomarkers. our aim was to develop a standardized protocol for reproducible peptidome profiling of CSF using magnetic bead (MB) separation followed by MALDI-TOF MS. Peptidome fractionation and profiling of CSF were performed using MBs with different surface functionalities. We investigated exogenous variables (storage conditions, freeze-thaw-cycles) and endogenous interferences (albumin, immunoglobulin, blood, leukocytes) in pooled CSF samples. we detected approximately 500 signals with an S/N ratio >10 and an overlap frequency of about 40% in non-pathological CSF. Within- and between-day imprecisions in relative signal intensities ranged from 3 to 28% and 7 to 47%, respectively. CSF storage at room temperature for up to 6 h and at 4 degrees C for up to 3 days did not significantly influence the mass spectra. Consecutive freeze-thaw-cycles significantly affected the mass spectra. High albumin and immunoglobulin content altered the CSF preparation using MB-HIC C8 beads. Blood contamination showed no effect on mass spectra up to a hemoglobin concentration of 0.075 mu mol/L. The presence of leukocytes up to a cell number of 30 Mpt/L did not affect mass spectra. Our reliable pretreatment protocol allows standardization of preanalytical modalities and thereby enables reproducible peptidome profiling of human CSF using MB separation followed by MALDI-TOF MS. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:608 / 615
页数:8
相关论文
共 23 条
[1]   The use of proteomics for the assessment of clinical samples in research [J].
Aldred, S ;
Grant, MM ;
Griffiths, HR .
CLINICAL BIOCHEMISTRY, 2004, 37 (11) :943-952
[2]   Standardized approach to proteome profiling of human serum based on magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry [J].
Baumann, S ;
Ceglarek, U ;
Fiedler, GM ;
Lembcke, J ;
Leichtle, A ;
Thiery, J .
CLINICAL CHEMISTRY, 2005, 51 (06) :973-980
[3]   Biomedical informatics for proteomics [J].
Boguski, MS ;
McIntosh, MW .
NATURE, 2003, 422 (6928) :233-237
[4]   Mass Spectrometry as a diagnostic and a cancer biomarker discovery tool - Opportunities and potential limitations [J].
Diamandis, EP .
MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (04) :367-378
[5]   Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience - Exemplified in amyotrophic lateral sclerosis biomarker discovery research [J].
Ekegren, Titti ;
Hanrieder, Joerg ;
Bergquist, Jonas .
JOURNAL OF MASS SPECTROMETRY, 2008, 43 (05) :559-571
[6]   Standardized peptidome profiling of human urine by magnetic bead separation and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry [J].
Fiedler, Georg Martin ;
Baumann, Sven ;
Leichtle, Alexander ;
Oltmann, Anke ;
Kase, Julia ;
Thiery, Joachim ;
Ceglarek, Uta .
CLINICAL CHEMISTRY, 2007, 53 (03) :421-428
[7]   Preanalytical impact of sample handling on proteome profiling experiments with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry [J].
Findeisen, P ;
Sismanidis, D ;
Riedl, M ;
Costina, V ;
Neumaier, M .
CLINICAL CHEMISTRY, 2005, 51 (12) :2409-2411
[8]   Proteomics: A new diagnostic frontier [J].
Hortin, GL ;
Jortani, SA ;
Ritchie, JC ;
Valdes, R ;
Chan, DW .
CLINICAL CHEMISTRY, 2006, 52 (07) :1218-1222
[9]   Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? [J].
Hortin, GL .
CLINICAL CHEMISTRY, 2005, 51 (01) :3-5
[10]   The MALDI-TOF mass spectrometric view of the plasma proteome and peptidome [J].
Hortin, Glen L. .
CLINICAL CHEMISTRY, 2006, 52 (07) :1223-1237